Table of Content

Part 1. Summary
Part 2. Introduction
? Study period
? Geographical scope
? Market segmentation
Part 3. Natural killer cell therapy market overview
Part 4. Market breakdown by therapy type
? CAR-NK cell therapy (modified)
? NK cell engager
? NK cell therapy (unmodified)
Part 5. Market breakdown by indication
? Acute myeloid leukemia (AML)
? Hepatocellular carcinoma (HCC)
? Peripheral T-cell lymphoma (PTCL)
? Relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (NHL)
Part 6. Market breakdown by region
? Asia Pacific
? Europe
? North America
Part 7. Key companies
? Acepodia Inc.
? Affimed N.V.
? Celularity Inc.
? Century Therapeutics, Inc.
? Cytovac A/S
? Dragonfly Therapeutics, Inc.
? Fate Therapeutics, Inc.
? Gamida-Cell Ltd.
? GC Biopharma Corp.
? Glycostem Therapeutics B.V.
? iCell Gene Therapeutics, LLC
? ImmunityBio, Inc.
? Innate Pharma S.A.
? Nkarta, Inc.
? Sanofi S.A.
? Senti Biosciences, Inc.
? Shoreline Biosciences, Inc.
? Takeda Pharmaceutical Company Limited
? VaxCell Biotherapeutics Co., Ltd.
Part 8. Methodology